The scientists at BSRC “Alexander Fleming” perform cutting-edge research, aiming to understand molecular mechanisms of complex biological processes in health and disease. We are also committed to contribute to innovation in medicine, by developing novel therapeutic and diagnostic methods, focusing on immunity and inflammation, cancer, and neurodegenerative diseases. To keep our focus on top-notch research, we recruit at all levels with excellence as the sole criterion and we support our researchers by providing state-of-the science infrastructures and a pleasant working environment. FLEMING is a non-profit organization operating under the auspices of the Greek General Secretariat for Research & Technology and is supported by the Greek government and by national, European and international grants.

Highlights

21/11/2017
21 November 2017

On behalf of the Scientists and Personnel of BSRC Fleming I would like to express our sadness for the loss of Fotis Kafatos, an innovative mind that has influenced and shaped the development of Molecular Biology in Europe and in Greece. We extend our condolences to his family and the many students and colleagues he inspired through the years. 
George Kollias, President and Director of BSRC Fleming.  

27/10/2017
27 October 2017

Recently published work from the Skoulakis lab suggests that cortical actin rearrangements underlie the little understood Anesthesia Resistant Memory, whose molecular mechanisms remained mysterious to date. Pubmed.

27/07/2017
27 July 2017

The Genomics Facility of the BSRC Alexander Fleming, in collaboration with the lab of Iannis Talianidis, has developed a new high-throughput method for sequencing nascent RNAs labeled in vivo.

20/07/2017
20 July 2017

BSRC Fleming has signed a MoU with the National Bank of Greece sharing the common vision of fostering innovation and entrepreneurship in emerging areas of modern research. This partnership aims to contribute to the translation of scientific achievements into clinical practice and the development of innovative products of high added value. Press Release (in Greek).

NEWS AND EVENTS

22/02/2018

Proteostatic Mechanisms in Health and Disease, The Final COST Action BM1307 Meeting, 22-24 February 2018, Divani Palace Acropolis, Athens, Greece

PUBLICATIONS

Visit BSRC Fleming's scientific Publications web page

FUNDING

Visit BSRC Fleming's funding web page

WebMail

For internal users

INTRANET

For internal users

B.S.R.C. "Alexander Fleming"
34 Fleming Street, 16672 Vari, Greece
Contact us